Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.5K Buy
+70
New +$15.3K ﹤0.01% 854
2026
Q2
– Sell
-3
Closed -$673 – 1157
2026
Q1
$673 Buy
+3
New +$748 ﹤0.01% 1044
2025
Q2
– Sell
-13
Closed -$2.91K – 1004
2025
Q1
$2.91K Sell
13
-1
-7% -$233 ﹤0.01% 892
2024
Q4
$3.2K Hold
14
– – ﹤0.01% 864
2024
Q3
$3.42K Buy
+14
New +$3.13K ﹤0.01% 842

Other funds holding RMD

Eastern Bank's RMD Position: Q3 2026 in Review

Eastern Bank opened a new position in ResMed (RMD) in Q3 2026: 70 shares worth $15.5K. The stake represents ﹤0.01% of the portfolio and ranks #854 among its holdings. This is a return to the name: Eastern Bank previously reported a position in RMD as recently as Q1 2026.

Eastern Bank first reported a position in RMD in Q3 2024 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Eastern Bank held 70 shares of ResMed worth $15.5K as of Q3 2026.
  • ResMed was a new Eastern Bank position in Q3 2026.
  • ResMed made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #854 holding.
  • Eastern Bank first reported a position in ResMed in Q3 2024 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.